Author:
Park Sohee,Choe Jooae,Lee Sang Min,Choi Sehoon,Kim Min-Ju,Chae Eun Jin,Seo Joon Beom
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA. 2019;69:7–34.
2. Gomez DR, Blumenschein GR Jr, Lee JJ, Hernandez M, Ye R, Camidge DR, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016;17:1672–82.
3. Gomez DR, Tang C, Zhang J, Blumenschein GR Jr, Hernandez M, Lee JJ, et al. Local consolidative therapy vs maintenance therapy or observation for patients with oligometastatic non-small cell lung cancer: long-term results of a multi-institutional, phase II, randomized study. J Clin Oncol. 2019;37:1558–65.
4. Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet London, England. 2019;393:2051–8.
5. National Comprehensive Cancer Network. Non-Small Cell Lung Cancer (version 3.2023). Retrieved September 18, 2023 at https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献